Re: OTC Expert & Grey Market Restrictions
in response to
by
posted on
Nov 22, 2022 02:51PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
I may have misunderstood the TD note. Sorry for the confusion.